These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2978385)

  • 21. Bactericidal activity of flucloxacillin and vancomycin in broth, human serum, in the presence of polymorphonuclear leukocytes and on the influence of phagocytosis and intracellular killing against staphylococci.
    Just HM; Rother P; Pinkawa M; Daschner F
    J Chemother; 1989 Jul; 1(4 Suppl):198-200. PubMed ID: 16312367
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro activity of aztreonam against gram negative bacteria from clinical specimens and its comparison with other commonly used antibiotics.
    Qadri SM; Belobraydic KA
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):223-6. PubMed ID: 3088346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic resistance: a local hospital or community problem.
    File TM; Haug MT; Thomson RB; Tan JS; Salstrom SJ; Tan L; Osborne V; Stephens C
    Bull N Y Acad Med; 1987 Apr; 63(3):231-6. PubMed ID: 3111574
    [No Abstract]   [Full Text] [Related]  

  • 24. Synergy studies of ciprofloxacin and other quinolone derivatives in combination with further antibiotics.
    Höffler U
    Chemioterapia; 1987 Jun; 6(2 Suppl):140-2. PubMed ID: 2855612
    [No Abstract]   [Full Text] [Related]  

  • 25. [Bacterial combination effect between carumonam and eight other antibiotics].
    Obana Y; Murakami T; Kuzui H; Nishino T
    Jpn J Antibiot; 1990 Dec; 43(12):2094-101. PubMed ID: 2128341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of spontaneous resistance to glycopeptide antibiotics in staphylococcal populations.
    Biavasco F; Montanari MP; Facinelli B; Varaldo PE
    J Chemother; 1989 Jul; 1(4 Suppl):389-90. PubMed ID: 16312453
    [No Abstract]   [Full Text] [Related]  

  • 27. A clinical trial of teicoplanin compared with a combination of flucloxacillin and tobramycin as antibiotic prophylaxis for cardiac surgery: the use of a scoring method to assess the incidence of wound infection.
    Wilson AP; Grüneberg RN; Treasure T; Sturridge MF
    J Hosp Infect; 1986 Mar; 7 Suppl A():105-12. PubMed ID: 2871092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sensitivity curves of multiply resistant corynebacteria JK and D2].
    Rauturier M; Darbas H; Jean-Pierre H; Boyer G; Rivière M
    Pathol Biol (Paris); 1990 May; 38(5):420-5. PubMed ID: 2142275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vancomycin resistance: are there better glycopeptides coming?
    Linden PK
    Expert Rev Anti Infect Ther; 2008 Dec; 6(6):917-28. PubMed ID: 19053904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Teicoplanin.
    Williams AH; Grüneberg RN
    J Antimicrob Chemother; 1984 Nov; 14(5):441-5. PubMed ID: 6239854
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro studies of synergistic interaction between aztreonam and cefoperazone.
    Borowski J; Zaremba M; Feliński J
    Chemioterapia; 1987 Jun; 6(2 Suppl):109-10. PubMed ID: 3151329
    [No Abstract]   [Full Text] [Related]  

  • 32. [In vitro effects of aztreonam against Pseudomonas aeruginosa].
    Marone P; Concia E; Perversi L; Monzillo V; Cruciani M
    G Ital Chemioter; 1985; 32(2):411-4. PubMed ID: 3938743
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro interactions between cefotetan and aminoglycosides on Klebsiella, Enterobacter and Serratia species.
    Debbia E; Stefani S; Nicoletti G; Schito GC
    Chemioterapia; 1987 Jun; 6(2 Suppl):94-5. PubMed ID: 3509543
    [No Abstract]   [Full Text] [Related]  

  • 34. Synergistic activity of vancomycin and teicoplanin alone and in combination with streptomycin against Enterococcus faecalis strains with various vancomycin susceptibilities.
    Babalola CP; Patel KB; Nightingale CH; Nicolau DP
    Int J Antimicrob Agents; 2004 Apr; 23(4):343-8. PubMed ID: 15081082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT; Liao CH; Teng LJ; Hsueh PR
    Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of the combination of teicoplanin or flucloxacillin with netilmicin in the treatment of Staphylococcus aureus bacteraemia.
    Degener JE; Vogel M; Michel MF; Mutsaers MM; Hop WC
    J Antimicrob Chemother; 1989 Jun; 23(6):899-904. PubMed ID: 2527224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro study of the sensitivity of 1030 hospital-isolated bacterial strains to aztreonam.
    Grassi L
    Chemioterapia; 1984 Aug; 3(4):262-6. PubMed ID: 6543433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bactericidal and bacteriolytic activities of carumonam and its effect on bacterial morphology.
    Nakao M; Kondo M; Imada A
    J Antimicrob Chemother; 1986 Apr; 17(4):433-9. PubMed ID: 3086273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ofloxacin: in-vitro activity against clinical isolates.
    Grima P
    Chemioterapia; 1985 Dec; 4(6):434-5. PubMed ID: 3938347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of Ro 17-2301, a new monobactam, against gram-negative bacteria resistant to aminoglycosides.
    Landinez R; Garcia M; Merino C
    Chemioterapia; 1987 Jun; 6(2 Suppl):112-4. PubMed ID: 3509365
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.